Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 469 All time
- Disclosed funding
- $19.1B 396 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| T TransfyrCompany profile Physical AI platform capturing real-world lab science into machine-readable data Physical AI platform capturing real-world lab science into machine-readable data | $25M | Seed | Biotech | United States | Investors | |
| AB Adaptyv BioCompany profile Adaptyv Bio runs automated laboratory experiments that help protein designers test their sequences and use measured results to improve the next design. Adaptyv Bio runs automated laboratory experiments that help protein designers test their sequences and use measured results to improve the next design. | $40M | Series A | Biotech | Switzerland | Investors | |
| AT Airway TherapeuticsCompany profile Airway Therapeutics develops biologic drug candidates for respiratory, inflammatory and infectious diseases. Airway Therapeutics develops biologic drug candidates for respiratory, inflammatory and infectious diseases. | $24M | Series E-2Series C+ | Biotech | United States | Investors | |
| O OmicsBankCompany profile Connects fragmented hospital data for drug development and healthcare AI research Connects fragmented hospital data for drug development and healthcare AI research | $2.3M | Seed | Biotech, Healthtech | United States | Investors | |
| PT Pixelgen TechnologiesCompany profile High-throughput platform mapping molecular cell architecture at nanoscale resolution High-throughput platform mapping molecular cell architecture at nanoscale resolution | $15.5M | Series B | Biotech | Sweden | Investors | |
| KI KaliVir ImmunotherapeuticsCompany profile Develops oncolytic immunotherapies for patients with advanced solid tumors Develops oncolytic immunotherapies for patients with advanced solid tumors | $14M | Series A | Biotech | United States | Investors | |
| NB Network BioCompany profile Builds AI models trained on patient tissue and clinical data for disease diagnostics Builds AI models trained on patient tissue and clinical data for disease diagnostics | $50M | StrategicUndisclosed | Biotech | United States | Investors | |
| A AuraGxPCompany profile AI-native SaaS platform connecting quality, procurement and vendor management for life sciences AI-native SaaS platform connecting quality, procurement and vendor management for life sciences | Undisclosed | Seed | Biotech | United States | Investors Undisclosed | |
| C ComputomicsCompany profile Machine learning platform predicting crop variety performance for climate-smart breeding Machine learning platform predicting crop variety performance for climate-smart breeding | €6.3M | Series B | Biotech, Agritech | Germany | Investors | |
| A AbcuroCompany profile Clinical-stage immunotherapies targeting pathogenic cytotoxic T cells in autoimmune disease. Clinical-stage immunotherapies targeting pathogenic cytotoxic T cells in autoimmune disease. | $66M | Series DSeries C+ | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.